3 Cannabis Stocks to Buy Ahead of the 3rd-Wave Rebound

A third-wave rebound in cannabis stocks could be on the horizon, so make sure to pick up these cannabis companies at cheap valuations!

Investors around the world are preparing for a major rebound after the pandemic. Economists predict a new “Roaring ’20s” that will see consumers putting their money into absolutely anything. That includes cannabis, and it’s why many investors believe a third-wave rebound is about to happen with cannabis stocks.

These companies have been preparing for a while now, cutting back costs and continuing the trend of consolidation. So, if you’re looking for cannabis stocks to ride the third wave now and years in the future, start with these three.

Tilray

Of course, we cannot talk about mergers and consolidation without talking about Tilray (TSX:TLRY)(NASDAQ:TLRY). The company’s very recent merger with Aphria means it is now potentially the leading producer and seller of cannabis products. It is, as of writing, the largest multinational cannabis company by revenue.

The move was to give the companies major access to the United States while combining with the free trade abilities in Europe. This now gives Tilray stock the opportunity to become a global operation, with revenue to match. On top of recreational cannabis production, Tilray stock is also developing craft beer, hemp, and CBD products.

The merger is recent, so share growth isn’t exactly stellar at the moment. But with a third wave in cannabis stocks on the horizon, now might be a great time to pick up Tilray stock. It currently trades at about $18 per share, with valuations at 3.7 times book value, making it one heck of a bargain.

Hexo

Speaking of bargains, you can still take advantage of this one with HEXO (TSX:HEXO)(NYSE:HEXO). The company has been consolidation central, snatching up two companies in the last few months. First it was Zenabis Global in February, and this week it was 48North Cannabis (TSXV:NRTH). This most recent $50 million deal will give the company $12 million in savings the first year alone and inch it closer to a top two cannabis producer position.

Part of the reason investors should consider this stock is its United States exposure. It recently partnered with a marketing company to expand its U.S. operations. Specifically, HEXO stock wants to expand its Truss CBD USA, the joint venture with Molson Coors, and its potential non-beverage CPG partners. In fact, while other cannabis stocks focus on recreational marijuana, HEXO stock continues to focus on packaged goods. And this seems to be the area where consumers will focus their interest.

Shares in HEXO stock are up 143% in the last year, falling in February from 52-week highs. That means today you can pick up HEXO stock shares at a deal at $7.50 per share as of writing, with valuations at 1.7 times book value!

Canopy Growth

Finally, the heavy hitter. Since cannabis stocks came on the scene, Canopy Growth (TSX:WEED)(NYSE:CGC) seemed to dominate. It’s held the top spot as the largest producer by market capitalization until just recently, when it was beat out by Tilray stock.

However, that could all change soon. After making severe cost-cutting measures, Canopy Growth stock is set up for success should U.S. legalization occur. It made several acquisitions that will come online with decriminalization. Meanwhile, it continues to expand its cannabis-infused beverage line, including with CBD.

Yet Canopy Growth stock remains at low levels, currently trading at $27.80. It won’t be until that third wave of cannabis consumption that we see cannabis stocks like Canopy Growth stock start to climb once again. Shares are up only 26% in the last year after a fall from 52-week highs in February, so you can pick it up at 2.6 times book value today!

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe owns shares of Canopy Growth and HEXO. The Motley Fool recommends HEXO. and HEXO.

More on Coronavirus

A airplane sits on a runway.
Coronavirus

3 Fresh Stocks I’m Likely Buying in 2025

I am likely buying Air Canada (TSX:AC) stock in 2025.

Read more »

RRSP Canadian Registered Retirement Savings Plan concept
Coronavirus

Canadian RRSP Stocks to Buy Now for Retirement

Alimentation Couche-Tard Inc (TSX:ATD) is a quality retirement stock.

Read more »

A train passes Morant's curve in Banff National Park in the Canadian Rockies.
Coronavirus

Retirees: What Rising Inflation Means for Your CPP Payments

If you aren't getting enough CPP, you can consider investing in stocks and ETFs. Canadian National Railway (TSX:CNR) is one…

Read more »

Coronavirus

Air Canada Stock Is Starting to Get Ridiculously Oversold

Air Canada (TSX:AC) has been beaten down to absurd lows.

Read more »

Coronavirus

Should You Buy Air Canada Stock While it’s Below $18?

Air Canada (TSX:AC) stock is below $18. Should you invest?

Read more »

Illustration of data, cloud computing and microchips
Stocks for Beginners

3 Canadian Stocks That Could Still Double in 2024

These three Canadians stocks have been huge winners already in 2024, but still have room to double again in the…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Can Air Canada Stock Recover in 2024?

Air Canada (TSX:AC) stock remains close to its COVID-19 era lows, even though its business has recovered.

Read more »

A airplane sits on a runway.
Coronavirus

3 Things to Know About Air Canada Stock Before You Buy

Air Canada stock continues to hover below $20 despite the sharp rise in travel demand seen across the industry. What's…

Read more »